IV.a
IV - Heart block (bundle branch-, AV-block)
Heart block (bundle branch- or AV-)
Last update 17/06/2026
AV block may be complete and/or irreversible
Back
The Drug-Induced Respiratory Disease Website
Causative drugs
18
II.d
II. Myocardial dysfunction - Heart failure
II.d Cardiovascular collapse - Cardiogenic shock - Hypotension
III.c
III. Myocardial ischemia - Coronary artery disease
III.c Coronary vasospasm - Vasospastic angina
IV.a
IV. Heart block (bundle branch-, AV-block)
IV.a Heart block (bundle branch- or AV-)
X.b
X. Pulmonary edema
X.b Pulmonary edema, noncardiogenic (NCPE)
XIV.e
XIV. Pleural involvement
XIV.e Hemothorax - Serosanguineous pleural effusion
XV.a
XV. Chest pain
XV.a Chest pain (acute or subacute), lone or prominent
XVI.e
XVI. Hemorrhage - Bleeding - Hematoma(s)
XVI.e Alveolar hemorrhage (AH), diffuse AH (DAH)
XVI.h
XVI. Hemorrhage - Bleeding - Hematoma(s)
XVI.h Coagulopathy
XVI.i
XVI. Hemorrhage - Bleeding - Hematoma(s)
XVI.i Hemoptysis
XX.c
XX. Vasculitis
XX.c Vascultis (pulmonary, extrathoracic or systemic) - ANCA status unknown or negative
XXII.b
XXII. Acute respiratory/cardiorespiratory failure
XXII.b Acute lung injury - ARDS
XXIV.b
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.b Pneumonitis (ILD), acute and/or severe (may cause ARDS)
XXIV.c
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.c Eosinophilic pneumonia (pulmonary infiltrates and eosinophilia)
XXIV.f
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.f Diffuse alveolar damage (DAD) imaging pattern
XXVIII.a
XXVIII. Large airway involvement
XXVIII.a Angioedema (may cause UAO, asphyxia and death)
XXIX.a
XXIX. Small airway involvement
XXIX.a Bronchospasm - Wheezing - Asthma
XXIX.c
XXIX. Small airway involvement
XXIX.c Severe or catastrophic bronchospasm or asthma attack (can be fatal)
XXXIII.j
XXXIII. Histopathology (for pulmonary pathology see in ‘Pneumotox’ (a free companion App)
XXXIII.j Path: Pulmonary edema
XXXVI.f
XXXVI. Autoimmune syndromes - Systemic reactions or conditions
XXXVI.f Anaphylaxis - Anaphylactoid reaction (either of these can be fatal)
I.a
I. Cardiac arrhythmia(s)/dysrhythmia(s) (AF, VT, VF, TdP) - QTc prolongation)
I.a Cardiac arrhythmias or dysrhythmias (AF, VT, VF, TdP)
I.b
I. Cardiac arrhythmia(s)/dysrhythmia(s) (AF, VT, VF, TdP) - QTc prolongation)
I.b Atrial fibrillation
II.a
II. Myocardial dysfunction - Heart failure
II.a Left ventricular dysfunction/failure
III.a
III. Myocardial ischemia - Coronary artery disease
III.a Coronary artery disease (acute) - Myocardial ischemia/infarction
IV.a
IV. Heart block (bundle branch-, AV-block)
IV.a Heart block (bundle branch- or AV-)
VI.a
VI. Cardiomyopathy
VI.a Cardiomyopathy (acute, subacute, chronic)
VI.c
VI. Cardiomyopathy
VI.c Takotsubo (stress) cardiomyopathy
VIII.a
VIII. Valvular heart disease
VIII.a Valvular heart disease and/or dysfunction
XI.a
XI. Pulmonary vasculopathies
XI.a Pulmonary arterial hypertension
XI.i
XI. Pulmonary vasculopathies
XI.i Pulmonary veno-occlusive disease
XII.b
XII. Pericardial involvement
XII.b Pericardial effusion (w/wo tamponade)
XXVI.a
XXVI. Neuromuscular dysfunction
XXVI.a Phrenic nerve injury - Hemi- or bilateral diaphragmatic paralysis
XXXVI.f
XXXVI. Autoimmune syndromes - Systemic reactions or conditions
XXXVI.f Anaphylaxis - Anaphylactoid reaction (either of these can be fatal)
XXXVIII.k
XXXVIII. Miscellaneous - Varia
XXXVIII.k Hypersensitivity reaction (may manifest with fever and/or skin, throat or airway involvement)
I.a
I. Cardiac arrhythmia(s)/dysrhythmia(s) (AF, VT, VF, TdP) - QTc prolongation)
I.a Cardiac arrhythmias or dysrhythmias (AF, VT, VF, TdP)
I.g
I. Cardiac arrhythmia(s)/dysrhythmia(s) (AF, VT, VF, TdP) - QTc prolongation)
I.g QTc prolongation
I.l
I. Cardiac arrhythmia(s)/dysrhythmia(s) (AF, VT, VF, TdP) - QTc prolongation)
I.l Cardiac- cardiorespiratory/pulmonary arrest
I.n
I. Cardiac arrhythmia(s)/dysrhythmia(s) (AF, VT, VF, TdP) - QTc prolongation)
I.n Respiratory arrest - Apnea
IV.a
IV. Heart block (bundle branch-, AV-block)
IV.a Heart block (bundle branch- or AV-)
V.b
V. Myocarditis
V.b Eosinophilic myocarditis
VI.a
VI. Cardiomyopathy
VI.a Cardiomyopathy (acute, subacute, chronic)
I.a
I. Cardiac arrhythmia(s)/dysrhythmia(s) (AF, VT, VF, TdP) - QTc prolongation)
I.a Cardiac arrhythmias or dysrhythmias (AF, VT, VF, TdP)
II.a
II. Myocardial dysfunction - Heart failure
II.a Left ventricular dysfunction/failure
IV.a
IV. Heart block (bundle branch-, AV-block)
IV.a Heart block (bundle branch- or AV-)
VI.a
VI. Cardiomyopathy
VI.a Cardiomyopathy (acute, subacute, chronic)
VII.a
VII. Cardiotoxicity
VII.a ‘Cardiotoxicity’
VII.b
VII. Cardiotoxicity
VII.b Veterinary: Cardiotoxicity
IX.b
IX. Endocardial involvement
IX.b Endocardial fibroelastosis
II.d
II. Myocardial dysfunction - Heart failure
II.d Cardiovascular collapse - Cardiogenic shock - Hypotension
IV.a
IV. Heart block (bundle branch-, AV-block)
IV.a Heart block (bundle branch- or AV-)
XV.a
XV. Chest pain
XV.a Chest pain (acute or subacute), lone or prominent
XXIV.a
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.a Pneumonitis (ILD)
XXIV.b
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.b Pneumonitis (ILD), acute and/or severe (may cause ARDS)
XXIV.c
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.c Eosinophilic pneumonia (pulmonary infiltrates and eosinophilia)
XXIV.h
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.h Pulmonary fibrosis (may improve but partly following drug discontinuation)
XXVII.a
XXVII. Dyspnea, lone
XXVII.a Dyspnea, unexplained otherwise
I.a
I. Cardiac arrhythmia(s)/dysrhythmia(s) (AF, VT, VF, TdP) - QTc prolongation)
I.a Cardiac arrhythmias or dysrhythmias (AF, VT, VF, TdP)
I.e
I. Cardiac arrhythmia(s)/dysrhythmia(s) (AF, VT, VF, TdP) - QTc prolongation)
I.e Bradycardia
I.f
I. Cardiac arrhythmia(s)/dysrhythmia(s) (AF, VT, VF, TdP) - QTc prolongation)
I.f Tachycardia
I.j
I. Cardiac arrhythmia(s)/dysrhythmia(s) (AF, VT, VF, TdP) - QTc prolongation)
I.j Asystole
I.l
I. Cardiac arrhythmia(s)/dysrhythmia(s) (AF, VT, VF, TdP) - QTc prolongation)
I.l Cardiac- cardiorespiratory/pulmonary arrest
II.d
II. Myocardial dysfunction - Heart failure
II.d Cardiovascular collapse - Cardiogenic shock - Hypotension
IV.a
IV. Heart block (bundle branch-, AV-block)
IV.a Heart block (bundle branch- or AV-)
V.a
V. Myocarditis
V.a Myocarditis (can be fulminate/fulminant)
V.b
V. Myocarditis
V.b Eosinophilic myocarditis
VI.a
VI. Cardiomyopathy
VI.a Cardiomyopathy (acute, subacute, chronic)
VII.a
VII. Cardiotoxicity
VII.a ‘Cardiotoxicity’
VII.b
VII. Cardiotoxicity
VII.b Veterinary: Cardiotoxicity
XIV.a
XIV. Pleural involvement
XIV.a Pleural effusion (uni or bilateral) (can accompany ILD induced by the drug)
XVI.e
XVI. Hemorrhage - Bleeding - Hematoma(s)
XVI.e Alveolar hemorrhage (AH), diffuse AH (DAH)
XXII.b
XXII. Acute respiratory/cardiorespiratory failure
XXII.b Acute lung injury - ARDS
I.a
I. Cardiac arrhythmia(s)/dysrhythmia(s) (AF, VT, VF, TdP) - QTc prolongation)
I.a Cardiac arrhythmias or dysrhythmias (AF, VT, VF, TdP)
I.g
I. Cardiac arrhythmia(s)/dysrhythmia(s) (AF, VT, VF, TdP) - QTc prolongation)
I.g QTc prolongation
I.i
I. Cardiac arrhythmia(s)/dysrhythmia(s) (AF, VT, VF, TdP) - QTc prolongation)
I.i Torsades de pointe
II.a
II. Myocardial dysfunction - Heart failure
II.a Left ventricular dysfunction/failure
IV.a
IV. Heart block (bundle branch-, AV-block)
IV.a Heart block (bundle branch- or AV-)
VI.a
VI. Cardiomyopathy
VI.a Cardiomyopathy (acute, subacute, chronic)
XI.a
XI. Pulmonary vasculopathies
XI.a Pulmonary arterial hypertension
XXIX.a
XXIX. Small airway involvement
XXIX.a Bronchospasm - Wheezing - Asthma
XXXIII.e
XXXIII. Histopathology (for pulmonary pathology see in ‘Pneumotox’ (a free companion App)
XXXIII.e Path: Lysosomal storage cardiomyopathy/cardiotoxicity
I.a
I. Cardiac arrhythmia(s)/dysrhythmia(s) (AF, VT, VF, TdP) - QTc prolongation)
I.a Cardiac arrhythmias or dysrhythmias (AF, VT, VF, TdP)
I.m
I. Cardiac arrhythmia(s)/dysrhythmia(s) (AF, VT, VF, TdP) - QTc prolongation)
I.m Sudden cardiac death
II.a
II. Myocardial dysfunction - Heart failure
II.a Left ventricular dysfunction/failure
II.c
II. Myocardial dysfunction - Heart failure
II.c Heart failure (biventricular, congestive)
II.d
II. Myocardial dysfunction - Heart failure
II.d Cardiovascular collapse - Cardiogenic shock - Hypotension
III.a
III. Myocardial ischemia - Coronary artery disease
III.a Coronary artery disease (acute) - Myocardial ischemia/infarction
IV.a
IV. Heart block (bundle branch-, AV-block)
IV.a Heart block (bundle branch- or AV-)
V.a
V. Myocarditis
V.a Myocarditis (can be fulminate/fulminant)
V.e
V. Myocarditis
V.e Necrotizing myocarditis (w/o evidence for CAD)
VI.c
VI. Cardiomyopathy
VI.c Takotsubo (stress) cardiomyopathy
VII.a
VII. Cardiotoxicity
VII.a ‘Cardiotoxicity’
X.a
X. Pulmonary edema
X.a Pulmonary edema, cardiogenic
XI.a
XI. Pulmonary vasculopathies
XI.a Pulmonary arterial hypertension
XII.b
XII. Pericardial involvement
XII.b Pericardial effusion (w/wo tamponade)
XIII.a
XIII. Thrombosis - Embolism
XIII.a Pulmonary embolism - Venous thrombosis/thrombo-embolism
XIV.a
XIV. Pleural involvement
XIV.a Pleural effusion (uni or bilateral) (can accompany ILD induced by the drug)
XIV.i
XIV. Pleural involvement
XIV.i Serositis - Polyserositis
XV.e
XV. Chest pain
XV.e Pleuritis (can cause chest pain)
XVI.h
XVI. Hemorrhage - Bleeding - Hematoma(s)
XVI.h Coagulopathy
XXI.a
XXI. Mediastinal involvement/injury
XXI.a Lymphadenopathy (intrathoracic)
XXII.b
XXII. Acute respiratory/cardiorespiratory failure
XXII.b Acute lung injury - ARDS
XXIV.a
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.a Pneumonitis (ILD)
XXIV.b
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.b Pneumonitis (ILD), acute and/or severe (may cause ARDS)
XXIV.c
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.c Eosinophilic pneumonia (pulmonary infiltrates and eosinophilia)
XXIV.d
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.d Acute eosinophilic pneumonia (AEP)
XXIV.e
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.e Relapsing or migrating pneumonitis/pneumonia (see also Id)
XXIV.h
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.h Pulmonary fibrosis (may improve but partly following drug discontinuation)
XXIV.i
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.i Progression, acceleration or exacerbation of preexisting ILD/fibrosis
XXIV.j
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.j Organizing pneumonia (OP/BOOP) pattern (an area or areas of consolidation on imaging)
XXIV.l
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.l Acute fibrinous organizing pneumonia (AFOP)
XXIV.o
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.o Rapidly progressive ILD/pulmonary fibrosis (Hamman-Rich syndrome)
XXIV.q
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.q Delayed ILD, -pneumonitis, -fibrosis
XXIV.v
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.v Radiation recall pneumonitis
XXIV.ab
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.ab Chronic pneumonitis/ILD
XXIV.ac
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.ac Shrinking lung syndrome
XXIX.a
XXIX. Small airway involvement
XXIX.a Bronchospasm - Wheezing - Asthma
XXIX.i
XXIX. Small airway involvement
XXIX.i Exacerbation or deterioration of preexisting COPD
XXX.h
XXX. Imaging features
XXX.h Imaging: Avid pleural uptake on PET-scan
XXXIII.f
XXXIII. Histopathology (for pulmonary pathology see in ‘Pneumotox’ (a free companion App)
XXXIII.f Path: Myocardial vasculitis
XXXVI.f
XXXVI. Autoimmune syndromes - Systemic reactions or conditions
XXXVI.f Anaphylaxis - Anaphylactoid reaction (either of these can be fatal)
XXXVI.q
XXXVI. Autoimmune syndromes - Systemic reactions or conditions
XXXVI.q Tumor lysis syndrome (TLS)
XXXVI.v
XXXVI. Autoimmune syndromes - Systemic reactions or conditions
XXXVI.v Temporal arteritis (Horton’s)
IV.a
IV. Heart block (bundle branch-, AV-block)
IV.a Heart block (bundle branch- or AV-)
V.a
V. Myocarditis
V.a Myocarditis (can be fulminate/fulminant)
V.b
V. Myocarditis
V.b Eosinophilic myocarditis
XXII.b
XXII. Acute respiratory/cardiorespiratory failure
XXII.b Acute lung injury - ARDS
XXIV.a
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.a Pneumonitis (ILD)
XXIV.b
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.b Pneumonitis (ILD), acute and/or severe (may cause ARDS)
XXIV.c
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.c Eosinophilic pneumonia (pulmonary infiltrates and eosinophilia)
XXIV.j
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.j Organizing pneumonia (OP/BOOP) pattern (an area or areas of consolidation on imaging)
XXIV.s
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.s ILD with a granulomatous component
XXXIII.c
XXXIII. Histopathology (for pulmonary pathology see in ‘Pneumotox’ (a free companion App)
XXXIII.c Path: Eosinophilic myocarditis
XXXVI.b
XXXVI. Autoimmune syndromes - Systemic reactions or conditions
XXXVI.b Lupus - Lupus syndrome
XXXVI.m
XXXVI. Autoimmune syndromes - Systemic reactions or conditions
XXXVI.m DRES syndrome - DRESS-like reaction - Drug hypersensitivity syndrome
I.k
I. Cardiac arrhythmia(s)/dysrhythmia(s) (AF, VT, VF, TdP) - QTc prolongation)
I.k Sinus arrest
IV.a
IV. Heart block (bundle branch-, AV-block)
IV.a Heart block (bundle branch- or AV-)
V.a
V. Myocarditis
V.a Myocarditis (can be fulminate/fulminant)
VII.a
VII. Cardiotoxicity
VII.a ‘Cardiotoxicity’
XXII.b
XXII. Acute respiratory/cardiorespiratory failure
XXII.b Acute lung injury - ARDS
XXXVIII.a
XXXVIII. Miscellaneous - Varia
XXXVIII.a Upper airway obstruction other than angioedema or hematoma
I.a
I. Cardiac arrhythmia(s)/dysrhythmia(s) (AF, VT, VF, TdP) - QTc prolongation)
I.a Cardiac arrhythmias or dysrhythmias (AF, VT, VF, TdP)
I.e
I. Cardiac arrhythmia(s)/dysrhythmia(s) (AF, VT, VF, TdP) - QTc prolongation)
I.e Bradycardia
I.g
I. Cardiac arrhythmia(s)/dysrhythmia(s) (AF, VT, VF, TdP) - QTc prolongation)
I.g QTc prolongation
I.i
I. Cardiac arrhythmia(s)/dysrhythmia(s) (AF, VT, VF, TdP) - QTc prolongation)
I.i Torsades de pointe
I.l
I. Cardiac arrhythmia(s)/dysrhythmia(s) (AF, VT, VF, TdP) - QTc prolongation)
I.l Cardiac- cardiorespiratory/pulmonary arrest
IV.a
IV. Heart block (bundle branch-, AV-block)
IV.a Heart block (bundle branch- or AV-)
VI.c
VI. Cardiomyopathy
VI.c Takotsubo (stress) cardiomyopathy
VII.a
VII. Cardiotoxicity
VII.a ‘Cardiotoxicity’
XXII.e
XXII. Acute respiratory/cardiorespiratory failure
XXII.e Respiratory failure from ventilatory depression (of neuromuscular cause or causes)
XXXVI.f
XXXVI. Autoimmune syndromes - Systemic reactions or conditions
XXXVI.f Anaphylaxis - Anaphylactoid reaction (either of these can be fatal)
XXXVIII.d
XXXVIII. Miscellaneous - Varia
XXXVIII.d Death following exposure or poisoning
I.a
I. Cardiac arrhythmia(s)/dysrhythmia(s) (AF, VT, VF, TdP) - QTc prolongation)
I.a Cardiac arrhythmias or dysrhythmias (AF, VT, VF, TdP)
I.j
I. Cardiac arrhythmia(s)/dysrhythmia(s) (AF, VT, VF, TdP) - QTc prolongation)
I.j Asystole
III.a
III. Myocardial ischemia - Coronary artery disease
III.a Coronary artery disease (acute) - Myocardial ischemia/infarction
III.c
III. Myocardial ischemia - Coronary artery disease
III.c Coronary vasospasm - Vasospastic angina
III.e
III. Myocardial ischemia - Coronary artery disease
III.e Coronary artery dissection
IV.a
IV. Heart block (bundle branch-, AV-block)
IV.a Heart block (bundle branch- or AV-)
V.a
V. Myocarditis
V.a Myocarditis (can be fulminate/fulminant)
XII.b
XII. Pericardial involvement
XII.b Pericardial effusion (w/wo tamponade)
XIV.a
XIV. Pleural involvement
XIV.a Pleural effusion (uni or bilateral) (can accompany ILD induced by the drug)
XIV.f
XIV. Pleural involvement
XIV.f Pneumothorax
XIV.l
XIV. Pleural involvement
XIV.l Pneumothorax, bilateral
XV.a
XV. Chest pain
XV.a Chest pain (acute or subacute), lone or prominent
XVI.e
XVI. Hemorrhage - Bleeding - Hematoma(s)
XVI.e Alveolar hemorrhage (AH), diffuse AH (DAH)
XVI.i
XVI. Hemorrhage - Bleeding - Hematoma(s)
XVI.i Hemoptysis
XXI.c
XXI. Mediastinal involvement/injury
XXI.c Pneumomediastinum
XXII.b
XXII. Acute respiratory/cardiorespiratory failure
XXII.b Acute lung injury - ARDS
XXII.e
XXII. Acute respiratory/cardiorespiratory failure
XXII.e Respiratory failure from ventilatory depression (of neuromuscular cause or causes)
XXIV.b
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.b Pneumonitis (ILD), acute and/or severe (may cause ARDS)
XXIV.c
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.c Eosinophilic pneumonia (pulmonary infiltrates and eosinophilia)
XXIV.d
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.d Acute eosinophilic pneumonia (AEP)
XXIV.k
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.k Pulmonary infiltrates
XXIV.y
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.y Exogenous lipoid pneumonia (subacute, acute)
XXIV.ad
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.ad Pulmonary alveolar proteinosis (PAP)
XXIV.ae
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.ae Pneumoconiosis (silicosis, talcosis...)
XXIV.af
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.af Hypersensitivity pneumonitis pattern
XXIX.d
XXIX. Small airway involvement
XXIX.d Cough (lone)
XXXVI.f
XXXVI. Autoimmune syndromes - Systemic reactions or conditions
XXXVI.f Anaphylaxis - Anaphylactoid reaction (either of these can be fatal)
XXXVIII.e
XXXVIII. Miscellaneous - Varia
XXXVIII.e Sniffing death - Death from inhalation of compound
II.d
II. Myocardial dysfunction - Heart failure
II.d Cardiovascular collapse - Cardiogenic shock - Hypotension
III.a
III. Myocardial ischemia - Coronary artery disease
III.a Coronary artery disease (acute) - Myocardial ischemia/infarction
IV.a
IV. Heart block (bundle branch-, AV-block)
IV.a Heart block (bundle branch- or AV-)
V.a
V. Myocarditis
V.a Myocarditis (can be fulminate/fulminant)
VII.a
VII. Cardiotoxicity
VII.a ‘Cardiotoxicity’
X.a
X. Pulmonary edema
X.a Pulmonary edema, cardiogenic
XII.b
XII. Pericardial involvement
XII.b Pericardial effusion (w/wo tamponade)
XII.n
XII. Pericardial involvement
XII.n Pleuropericarditis - Pleuropericardial effusion (ANA unknown or negative)
XXII.b
XXII. Acute respiratory/cardiorespiratory failure
XXII.b Acute lung injury - ARDS
XXVIII.k
XXVIII. Large airway involvement
XXVIII.k Rhinosinusitis
XXIX.a
XXIX. Small airway involvement
XXIX.a Bronchospasm - Wheezing - Asthma
XXIX.e
XXIX. Small airway involvement
XXIX.e Obliterative bronchiolitis (an imaging and/or pathological pattern consistent with)
XXIX.i
XXIX. Small airway involvement
XXIX.i Exacerbation or deterioration of preexisting COPD
XXIX.l
XXIX. Small airway involvement
XXIX.l Bronchiolitis (a clinical-imaging pattern suggestive of)
XXXII.e
XXXII. Esophageal pathology
XXXII.e Esophageal toxicity
XXXII.j
XXXII. Esophageal pathology
XXXII.j Esophageal necrosis
XXXVI.m
XXXVI. Autoimmune syndromes - Systemic reactions or conditions
XXXVI.m DRES syndrome - DRESS-like reaction - Drug hypersensitivity syndrome
XXXVI.q
XXXVI. Autoimmune syndromes - Systemic reactions or conditions
XXXVI.q Tumor lysis syndrome (TLS)
II.c
II. Myocardial dysfunction - Heart failure
II.c Heart failure (biventricular, congestive)
IV.a
IV. Heart block (bundle branch-, AV-block)
IV.a Heart block (bundle branch- or AV-)
V.a
V. Myocarditis
V.a Myocarditis (can be fulminate/fulminant)
XI.a
XI. Pulmonary vasculopathies
XI.a Pulmonary arterial hypertension
XII.b
XII. Pericardial involvement
XII.b Pericardial effusion (w/wo tamponade)
XII.n
XII. Pericardial involvement
XII.n Pleuropericarditis - Pleuropericardial effusion (ANA unknown or negative)
XIII.a
XIII. Thrombosis - Embolism
XIII.a Pulmonary embolism - Venous thrombosis/thrombo-embolism
XXIV.a
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.a Pneumonitis (ILD)
XXIV.b
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.b Pneumonitis (ILD), acute and/or severe (may cause ARDS)
XXVIII.i
XXVIII. Large airway involvement
XXVIII.i Tongue involvement (edema, glossitis, hematoma)
XXIX.a
XXIX. Small airway involvement
XXIX.a Bronchospasm - Wheezing - Asthma
XXIX.i
XXIX. Small airway involvement
XXIX.i Exacerbation or deterioration of preexisting COPD
XXXIII.a
XXXIII. Histopathology (for pulmonary pathology see in ‘Pneumotox’ (a free companion App)
XXXIII.a Path: Myocarditis
XXXIII.f
XXXIII. Histopathology (for pulmonary pathology see in ‘Pneumotox’ (a free companion App)
XXXIII.f Path: Myocardial vasculitis
XXXVI.f
XXXVI. Autoimmune syndromes - Systemic reactions or conditions
XXXVI.f Anaphylaxis - Anaphylactoid reaction (either of these can be fatal)
XXXVI.h
XXXVI. Autoimmune syndromes - Systemic reactions or conditions
XXXVI.h Myasthenia gravis - Myasthenic-like syndrome
XXXVI.v
XXXVI. Autoimmune syndromes - Systemic reactions or conditions
XXXVI.v Temporal arteritis (Horton’s)
XXXVI.ad
XXXVI. Autoimmune syndromes - Systemic reactions or conditions
XXXVI.ad Polymyalgia rheumatica